In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.
Magazine
Olive tree (Olea europaea) leaf extract (OELE) has important antioxidant and anti-inflammatory properties, supporting its use in human clinical practice (1). A clinical trial and a sub-analysis of it conducted with the amorphous hydrogel EHO-85, containing OELE, for skin ulcer treatments were recently published (2-3). In a new publication, the effect of EHO-85 on healing was evaluated in comparison with treatments containing Centella asiatica, hyaluronic acid, or dexpanthenol in a rat model.
A sub-analysis of previous clinical trial (1) conducted with the EHO-85 hydrogel in the treatment of patients with pressure ulcers, venous ulcers or diabetic foot has recently been published in the journal Pharmaceutics (2). On this occasion, the aim was to analyse the ability of the EHO-85 hydrogel to accelerate wound healing compared to a commonly used reference hydrogel.
A novel mode of action to promote antibiotic-sparing approach to Recurrent UTIs: Questions and Answers on Clinical Practice1
Consultations for recurrent urinary tract infections (rUTIs) in everyday clinical practice range from 1% to 6% of all medical visits with high social and personal associated costs, such as prescriptions, hospital expenses, days of sick leave due to the disease, and the treatment of related comorbidities. Often urologists are asked to give practical recommendations to patients regarding the everyday management of recurrent UTIs. A new review1 aims to give to the physicians managing UTI some helpful suggestions for their everyday clinical practice, based on the recent evidence.